SecBot SecBot
8-K ·Filed Sep 14, 2026

DXCM

DEXCOM INC
NEUTRAL
Impact 2/10
Horizonmonths Processed2mo ago SEC0001093557-26-000175
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

This is a routine organizational change with no immediate financial impact. Monitor the next 10-Q for any operational efficiency metrics or margin commentary that may result from the expanded COO role.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$86.45
T+0 close · Sep 14, 2026 · via day close
Latest settled
−1.61%
T+20 · $85.06 · next T+60 in 22d
Vs SPY
−4.33%
α at T+20
Latest observation
−4.98%
T+42 · FF3 residual α
  1. T+0 · Sep 15 $86.45entry
  2. T+1 · 2mo ago +1.03%α +1.47% · $87.34
  3. T+5 · 8w ago +3.56%α +1.44% · $89.53
  4. T+20 · 5w ago −1.61%α −4.33% · $85.06
  5. T+44 · todayOpen
  6. T+60 · in 22d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

DexCom promoted CFO Jereme Sylvain to also serve as COO, effective September 14, 2026. His new offer letter provides an annual base salary of $767,000 and a 75% target bonus. This is a routine internal promotion combining finance and operations oversight, with no financial data or guidance provided.

Key Facts

  • Jereme Sylvain promoted to EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026.
  • New annual base salary of $767,000 and annual target bonus opportunity equal to 75% of base salary.
  • Sylvain will assume oversight of global operations and quality teams in addition to his CFO duties.

Financial Impact

No financial figures reported; compensation details are routine.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (36 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001093557-26-000175
Document: dxcm20260914-exhibit991.htm0001093557-26-000175
Document: 0001093557-26-000175-index-headers.html0001093557-26-000175
Document: 0001093557-26-000175-index.html0001093557-26-000175
Document: 0001093557-26-000175.txt0001093557-26-000175

Track record

16 reports on DXCM

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $79.92 Now $83.33 +4.27% settles Nov 17
  2. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $82.97 to $79.92 Now $83.33 +0.43% ▼ −3.68% −3.09% vs SPY
  3. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $82.29 to $79.41 Now $83.33 +1.26% ▼ −3.50% −0.80% vs SPY
  4. Oct 27, 202620d ago 144 Neutral 2/10 Entry $78.62 to $88.48 Now $83.33 +5.99% ▲ +12.54% +13.25% vs SPY
  5. Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $87.93 to $87.47 Now $83.33 +5.23% ▲ +0.52% +1.12% vs SPY
  6. Sep 14, 20269w ago 8-K Neutral 2/10 Viewing Entry $86.45 to $89.53 Now $83.33 −3.61% ▲ +3.56% +1.44% vs SPY
  7. Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $91.06 to $84.53 Now $83.33 −8.49% ▼ −7.17% −7.03% vs SPY
  8. Aug 24, 202612w ago Insider Cluster Neutral 2/10 Entry $89.16 to $90.14 Now $83.33 −6.54% ▲ +1.10% +1.64% vs SPY
  9. Aug 17, 202613w ago Insider Cluster Neutral 2/10 Entry $89.60 to $89.16 Now $83.33 −7.00% ▼ −0.49% −0.29% vs SPY
  10. Jul 21, 202616w ago Insider Cluster Neutral 2/10 Entry $71.43 to $75.14 Now $83.33 +16.66% ▲ +5.19% +7.60% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (12h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026